Skip to main content

View full-text article in PMC

. 2022 Jan 18;13(1):e02434-21. doi: 10.1128/mbio.02434-21

TABLE 1.

Antimicrobial susceptibility in P. aeruginosa PA14 overexpressing nox^Sp or FDH1^Cb as determined by the Etest^a

Antimicrobial	MIC (μg mL⁻¹)^b
	Empty vector		nox ^Sp		Empty vector^c		FDH1^Cb ^c
	Not induced	1 mM IPTG	Not induced	1 mM IPTG	Not induced	1 mM IPTG	Not induced	1 mM IPTG
Levofloxacin	0.38	0.38	0.25	0.25	0.38	0.38	0.38	1.5
Ciprofloxacin	0.125	0.19	0.125	0.094	0.125	0.19	0.125	0.5
Amikacin	3	4	3	2	3	4	3	12
Tobramycin	2	4	1	1.5	2	3	1	2
Meropenem	0.25	0.25	0.25	0.125	0.25	0.25	0.25	0.094
Ceftazidime	0.5	0.75	0.38	0.38	0.5	0.5	0.5	0.25

^a

MIC, minimal inhibitory concn; IPTG, isopropyl β-d-1-thiogalactopyranoside.

^b

Reported by the Etest assay.

^c

LB-agar supplemented with 10 mM sodium formate.